TPH1 and carcinoid syndrome: For pNET patients with carcinoid syndrome (less than 1%) [19], telotristat ethyl is an oral tryptophan hydroxylase 1 (TPH1) inhibitor that can provide relief from symptoms, particularly by decreasing the number of daily bowel movements [20].